| Tuberculosis associated with infliximab, a tumor necrosis factor α–neutralizing agent J Keane, S Gershon, RP Wise, E Mirabile-Levens, J Kasznica, ... New England Journal of Medicine 345 (15), 1098-1104, 2001 | 4797 | 2001 |
| A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars TJ Török, RV Tauxe, RP Wise, JR Livengood, R Sokolow, S Mauvais, ... Jama 278 (5), 389-395, 1997 | 883 | 1997 |
| Thromboembolic adverse events after use of recombinant human coagulation factor VIIa KA O’Connell, JJ Wood, RP Wise, JN Lozier, MM Braun Jama 295 (3), 293-298, 2006 | 792 | 2006 |
| Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)—United States, 1991–2001 W Zhou, V Pool, JK Iskander, R English-Bullard, R Ball, RP Wise, P Haber, ... MMWR Surveill Summ 52 (1), 1-24, 2003 | 557 | 2003 |
| Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept JH Lee, NR Slifman, SK Gershon, ET Edwards, WD Schwieterman, ... Arthritis & Rheumatism 46 (10), 2565-2570, 2002 | 546 | 2002 |
| Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States RT Chen, JW Glasser, PH Rhodes, RL Davis, WE Barlow, RS Thompson, ... Pediatrics 99 (6), 765-773, 1997 | 427 | 1997 |
| Postlicensure safety surveillance for varicella vaccine RP Wise, ME Salive, MM Braun, GT Mootrey, JF Seward, LG Rider, ... Jama 284 (10), 1271-1279, 2000 | 264 | 2000 |
| An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system JA Singleton, JC Lloyd, GT Mootrey, ME Salive, RT Chen, S Ellenberg, ... Vaccine 17 (22), 2908-2917, 1999 | 241 | 1999 |
| Guidelines for submitting adverse event reports for publication WN Kelly, FM Arellano, J Barnes, U Bergman, IR Edwards, AM Fernandez, ... Pharmacoepidemiology and drug safety 16 (5), 581-587, 2007 | 201 | 2007 |
| Adverse events reported following live, cold-adapted, intranasal influenza vaccine HS Izurieta, P Haber, RP Wise, J Iskander, D Pratt, CA Mink, S Chang, ... Jama 294 (21), 2720-2725, 2005 | 187 | 2005 |
| Guidelines for good pharmacoepidemiology practice (GPP) Public Policy Committee, International Society of Pharmacoepidemiology Pharmacoepidemiology and Drug Safety 25 (1), 2-10, 2016 | 155 | 2016 |
| Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995–2005 SS Chaves, P Haber, K Walton, RP Wise, HS Izurieta, DS Schmid, ... The Journal of infectious diseases 197 (Supplement_2), S170-S177, 2008 | 153 | 2008 |
| Hair loss after routine immunizations RP Wise, KP Kiminyo, ME Salive Jama 278 (14), 1176-1178, 1997 | 144 | 1997 |
| Babesia Infection through Blood Transfusions: Reports Received by the US Food and Drug Administration, 1997–2007 DM Gubernot, CT Lucey, KC Lee, GB Conley, LG Holness, RP Wise Clinical Infectious Diseases 48 (1), 25-30, 2009 | 131 | 2009 |
| Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States H Takahashi, V Pool, TF Tsai, RT Chen, TVWGC for Disease, S Ellenberg, ... Vaccine 18 (26), 2963-2969, 2000 | 129 | 2000 |
| Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system R Ball, LK Ball, RP Wise, MM Braun, JA Beeler, ME Salive, ... The pediatric infectious disease journal 20 (2), 219-223, 2001 | 122 | 2001 |
| Vasculitis as an adverse event following immunization–systematic literature review C Bonetto, F Trotta, P Felicetti, GS Alarcón, C Santuccio, NS Bachtiar, ... Vaccine 34 (51), 6641-6651, 2016 | 120 | 2016 |
| Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004 CE Zinderman, L Landow, RP Wise Journal of vascular surgery 43 (5), 1004-1009, 2006 | 120 | 2006 |
| Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine RP Wise, J Iskander, RD Pratt, S Campbell, R Ball, RP Pless, MM Braun Jama 292 (14), 1702-1710, 2004 | 116 | 2004 |
| Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994) J Beeler, F Varricchio, R Wise The Pediatric infectious disease journal 15 (1), 88-90, 1996 | 111 | 1996 |
